FDA Approves BYDUREON(TM) -- The First and Only Once-Weekly Treatment for Type 2 Diabetes Provides Glycemic Control in a Once-Weekly Dose - CNBCBYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes in multiple clinical settings. BYDUREON will be available in pharmacies nationwide in February.Weight loss is key in fighting type 2 diabetes - San Francisco GateSome people will still need medications, but the drugs work better with diet and physical activity. As the Centers for Disease Control puts it, "all diabetes-care programs should make healthy weight a priority." Dietary advice for type 2 ...Lifestyle changes help roll back Type II diabetes - Greenville NewsFind out more about how food and fitness work hand-in-hand to help control or even halt Type II ... While it’s true that diet plays a role in the onset of Type II diabetes, it’s more of a lifestyle disease than an indictment of fried chicken.